Kap95 inhibitors represent a class of chemical compounds that have garnered significant interest in the field of molecular biology and cellular transport research. These inhibitors are specifically designed to target and modulate the activity of Kap95, also known as karyopherin-β1 or importin-β, which is a key player in the nuclear transport machinery within eukaryotic cells. Kap95 is a member of the karyopherin family of proteins that mediate the nucleocytoplasmic transport of macromolecules, such as proteins and ribonucleoprotein complexes. It acts as a crucial adapter protein, facilitating the transport of cargo molecules into the cell nucleus by interacting with nuclear localization signals (NLS) on cargo proteins and other nucleoporins on the nuclear envelope.
Kap95 inhibitors exert their effects by disrupting the interactions between Kap95 and its cargo molecules or by interfering with the Kap95-dependent transport process itself. This interference can have profound implications for cellular functions that rely on precise control of nucleocytoplasmic transport, including gene expression, cell cycle regulation, and the maintenance of cellular homeostasis. Researchers employ Kap95 inhibitors as essential tools to investigate the molecular mechanisms underlying nuclear transport and the dynamics of nucleocytoplasmic shuttling. While the specific applications and broader implications of Kap95 inhibitors continue to be subjects of ongoing research, their utility in unraveling the complexities of cellular transport processes and their role in cellular physiology is of paramount importance in the field of cell biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
By binding to RNA polymerase, it can inhibit RNA synthesis and potentially lower Kap95 expression. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Mimics a tyrosyl-tRNA, causing premature chain termination during translation which might reduce Kap95 protein levels. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Inhibits peptide bond formation by binding to the 60S ribosomal subunit, potentially reducing Kap95 protein synthesis. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
Blocks polypeptide elongation during translation which could lead to a reduction in Kap95 protein. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $440.00 $900.00 $1400.00 $2502.00 | ||
Inhibits protein synthesis by blocking translocation of the ribosome along mRNA, potentially decreasing Kap95 levels. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
A cyclin-dependent kinase inhibitor that can suppress cell cycle progression and indirectly reduce Kap95 expression. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
A proteasome inhibitor that could indirectly affect Kap95 expression by altering protein degradation pathways. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Binds to heat shock protein 90 (Hsp90) and can affect its client proteins, potentially altering Kap95 expression indirectly. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that can modulate multiple signaling pathways, potentially leading to decreased Kap95 expression. | ||||||